[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Sciclone Pharmaceut (SCLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2016	12-2015	09-2015	06-2015	03-2015
Assets
Current Assets
Cash & Cash Equivalents	114,689	114,229	99,224	92,974	96,036
Marketable Securities	N/A	N/A	N/A	75	75
Receivables	32,434	39,363	40,210	37,900	32,426
Inventories	12,158	10,976	12,147	12,017	8,934
Income taxes - deferred	231	299	306	196	253
TOTAL	$162,227	$168,521	$153,820	$146,417	$140,056

Non-Current Assets
PPE Net	2,389	2,651	2,219	2,457	2,499
Intangibles	33,215	32,979	33,686	34,500	34,521
Other Non-Current Assets	12,519	12,468	12,507	12,526	5,266
TOTAL	$48,123	$48,098	$48,412	$49,483	$42,286

Total Assets	$210,350	$216,619	$202,232	$195,900	$182,342

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	3,267	4,495	3,803	5,365	2,415
Accrued Expenses	17,380	32,151	32,188	29,873	16,316
TOTAL	$20,766	$36,820	$36,194	$35,238	$18,841

Non-Current Liabilities
Deferred Revenues	119	174	203	N/A	110
Other Non-Current Liabilities	83	87	33	62	87
TOTAL	$83	$87	$33	$62	$87

Total Liabilities	$20,849	$36,907	$36,227	$35,300	$18,928

Shareholders' Equity
Shares Outstanding, K	49,909	49,624	49,377	50,251	49,602
Common Shares	50	50	49	50	50
Retained earnings	-110,630	-118,494	-131,039	-135,459	-128,936
Other shareholders' equity	2,267	2,070	2,646	3,307	3,320
TOTAL	$189,501	$179,712	$166,005	$160,600	$163,414

Total Liabilities And Equity	$210,350	$216,619	$202,232	$195,900	$182,342